Label: VICHY LABORATORIES LIFTACTIV PEPTIDE-C SPF 30 PHYTO PEPTIDES VITAMIN C- avobenzone, homosalate, octisalate and octocrylene lotion
- NDC Code(s): 49967-684-01, 49967-684-02, 49967-684-03
- Packager: L'Oreal USA Products Inc
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated December 11, 2023
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients
- Purpose
- Uses
- Warnings
- Do not use
- When using this product
- Stop use and ask a doctor if
- Keep out of reach of children.
-
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- reapply at least every 2 hours
- use a water resistant sunscreen if swimming or sweating
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a suncreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m.-2 p.m.
- wear long-sleeved shirts, pants, hats, and sunglasses
- children under 6 months of age: Ask a doctor
- Other information
-
Inactive ingredients
water, glycerin, dimethicone, silica, PEG-100 stearate, glyceryl stearate, glycolic acid, stearic acid, dicaprylyl carbonate, steareth-100, dimethicone/vinyl dimethicone crosspolymer, sodium hydroxide, sodium hyaluronate, myristic acid, cyclodextrin, palmitic acid, phenoxyethanol, henylethyl resorcinol, guanosine, ammonium polyacryloyldimethyl taurate, ascorbyl glucoside, tocopherol, caprylyl glycol, trisodium ethylenediamine disuccinate, xanthan gum, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, pisum sativum (pea) extract, fragrance
- Questions or comments?
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
VICHY LABORATORIES LIFTACTIV PEPTIDE-C SPF 30 PHYTO PEPTIDES VITAMIN C
avobenzone, homosalate, octisalate and octocrylene lotionProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:49967-684 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE 30 mg in 1 mL HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE 50 mg in 1 mL OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE 50 mg in 1 mL OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE 70 mg in 1 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) GLYCERIN (UNII: PDC6A3C0OX) DIMETHICONE (UNII: 92RU3N3Y1O) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) PEG-100 STEARATE (UNII: YD01N1999R) GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) GLYCOLIC ACID (UNII: 0WT12SX38S) STEARIC ACID (UNII: 4ELV7Z65AP) DICAPRYLYL CARBONATE (UNII: 609A3V1SUA) STEARETH-100 (UNII: 4OH5W9UM87) DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5) SODIUM HYDROXIDE (UNII: 55X04QC32I) HYALURONATE SODIUM (UNII: YSE9PPT4TH) MYRISTIC ACID (UNII: 0I3V7S25AW) BETADEX (UNII: JV039JZZ3A) PALMITIC ACID (UNII: 2V16EO95H1) PHENOXYETHANOL (UNII: HIE492ZZ3T) PHENYLETHYL RESORCINOL (UNII: G37UFG162O) GUANOSINE (UNII: 12133JR80S) AMMONIUM POLYACRYLOYLDIMETHYL TAURATE (55000 MPA.S) (UNII: F01RIY4371) ASCORBYL GLUCOSIDE (UNII: 2V52R0NHXW) TOCOPHEROL (UNII: R0ZB2556P8) caprylyl glycol (UNII: 00YIU5438U) TRISODIUM ETHYLENEDIAMINE DISUCCINATE (UNII: YA22H34H9Q) XANTHAN GUM (UNII: TTV12P4NEE) PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS) PEA (UNII: W4X7H8GYFM) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:49967-684-01 1 in 1 CARTON 12/27/2019 12/27/2019 1 50 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 2 NDC:49967-684-02 1 mL in 1 PACKET; Type 0: Not a Combination Product 12/27/2019 12/27/2022 3 NDC:49967-684-03 1 in 1 CARTON 12/27/2019 3 50 mL in 1 TUBE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M020 12/27/2019 Labeler - L'Oreal USA Products Inc (002136794) Establishment Name Address ID/FEI Business Operations Cosmetique Active Products 282658798 manufacture(49967-684) , pack(49967-684)